56962-08-4 = 942-06-3 反应条件:1.1 Catalysts: Niobium Pentoxide Solvents: O-Xylene; Rt -> 160 °C; 72 H,160 °C 标题:Heterogeneous Catalysts For The Cyclization Of Dicarboxylic Acids To Cyclic Anhydrides As Monomers For Bioplastic Production 作者:Rashed,N. Md.; Siddiki,S. M. A. H.; Ali,A. Md.; Moromi,Sondomoyee K.; Touchy,Abeda S.; Et Al 参考文献:Green Chemistry 日期:2017 卷标:19(14) 页码:3238-3242]
56962-08-4 = 942-06-3 反应条件:1.1 Solvents: Acetic Anhydride; Rt -> 110 °C; 1 H,110 °C -> 140 °C 标题:Preparation Method Of Octafluoro Substituted Phthalocyanine 参考文献:China]
56962-08-4 = 942-06-3 反应条件:1.1 Reagents: Acetic Anhydride 标题:Studies On The Chemistry Of Isoindoles And Isoindolenines. Xxvii. 3-Alkoxy-1H-Isoindoles: Syntheses And Properties 作者:Hennige,Hans; Kreher,Richard P.; Konrad,Michael; Jelitto,Frank 参考文献:Chemische Berichte 日期:1988 卷标:121(2) 页码:243-52]
89894-51-9 = 942-06-3 反应条件:1.1 Reagents: Carbon Solvents: 1,2,4-Trichlorobenzene 标题:Aromatization Of Halogenated Tetrahydrophthalic Anhydrides With Activated Carbon. An Effective Preparation Of 4,5-Dichlorophthalic Anhydride 作者:Fertel,Lawrence B.; Spohn,Ronald F.; O'Reilly,Neil J.; Lin,Henry C. 参考文献:Synlett 日期:1990 卷标:(9) 页码:539-40]
56962-08-4 = 942-06-3 反应条件:1.1 Reagents: Acetic Anhydride; 5 H,Rt -> Reflux 标题:Synthesis Of Water Soluble Pegylated (Copper) Phthalocyanines Via Mitsunobu Reaction And Cu(I)-Catalysed Azide-Alkyne Cycloaddition (Cuaac) "Click" Chemistry 作者:Li,Muxiu; Khoshdel,Ezat; Haddleton,David M. 参考文献:Polymer Chemistry 日期:2013 卷标:4(16) 页码:4405-4411]
= 942-06-3 反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Water 标题:Studies On Copper Phthalocyanine Pigments (I): Synthesis Of Chlorinated Phthalic Anhydrides And Their Reaction Velocity Rations In The Synthesis Of Chlorinated Copper Phthalocyanines 作者:Takesita,Masaaki 参考文献:Shikizai Kyokaishi 日期:1960 卷标:33(11) 页码:491-494]
56962-08-4 = 942-06-3 反应条件:1.1 Reagents: Acetic Anhydride 标题:Efficient Semitransparent Organic Solar Cells With Tunable Color Enabled By An Ultralow-Bandgap Nonfullerene Acceptor 作者:Cui,Yong; Yang,Chenyi; Yao,Huifeng; Zhu,Jie; Wang,Yuming; Et Al 参考文献:Advanced Materials (Weinheim 日期:2017 卷标:29(43)
专利号:US-8017776-B2 优先权日:2003-07-15 标题 :Methods for synthesis of acyloxyalkyl compounds 发明人:BHAT LAXMINARAYAN; GALLOP MARK A 权利人:XENOPORT INC 摘要:Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.
专利号:EP-2354120-A1 优先权日:2003-08-20 标题 :Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof 发明人:GALLOP MARK A; YAO FENMEI; LUDWIKOW MARIA J; PHAN THU; PENG GE 权利人:XENOPORT INC 摘要:The present invention relates to acyloxyalkyl carbamate prodrugs of (±)-4-amino-3-(4-fluorophenyl)butanoic acid and analogs thereof, pharmaceutical compositions thereof, methods of making prodrugs of (±)-4-amino-3-(4-fluorophenyl)butanoic acid and analogs thereof, methods of using prodrugs of (±)-4-amino-3-(4-tluorophenyl)butanoic acid and analogs thereof, and pharmaceutical compositions thereof for treating or preventing common diseases and/or disorders such as spasticity and/or acid reflux disease. The present invention also relates to acyloxyalkyl carbamate prodrugs of (±)-4-amino-3-(4-fluorophenyl)butanoic acid and analogs thereof which are suitable for oral administration and to sustained release oral dosage forms thereof.
专利号:US-5436368-A 优先权日:1990-10-31 标题:Intermediates in the preparation of 4,5-difluoroanthranillic acid 发明人:BRAISH TAMIM F 权利人:PFIZER 摘要:Compounds of the formula ##STR1## which are intermediates in the preparation of 4,5-difluoroanthranilic acid, an intermediate itself in the synthesis of quinolone antibacterials, and methods of preparing these intermediates.
专利号:US-8372881-B2 优先权日:2005-06-20 标题 :Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use 发明人:ZERANGUE NOA; JANDELEIT BERND; LI YUNXIAO; GALLOP MARK A 权利人:XENOPORT INC; ZERANGUE NOA; JANDELEIT BERND; LI YUNXIAO; GALLOP MARK A 摘要:Acyloxyalkyl carbamate prodrugs of trans-4-(aminomethyl)-cyclohexanecarboxylic acid, pharmaceutical compositions thereof, methods of making prodrugs of trans-4-(aminomethyl)-cyclohexane-carboxylic acid, and methods of using prodrugs of trans-4-(aminomethyl)-cyclohexanecarboxylic acid and pharmaceutical compositions thereof to treat or prevent various diseases or disorders are disclosed. Acyloxyalkyl carbamate prodrugs of trans-4-(aminomethyl)-cyclohexanecarboxylic acid and pharmaceutical compositions thereof suitable for oral and topical administration and for administration using sustained release dosage forms are also disclosed.
专利号:US-11472838-B2 优先权日:2018-04-17 标 题:Inhibitors of blood coagulation factor XIII 发明人:HILS MARTIN; PASTERNACK RALF; BÜCHOLD CHRISTIAN 权利人:ZEDIRA GMBH 摘要:The invention relates to a compound of general formula (I) as novel inhibitor of blood coagulation factor XIII, methods for synthesis thereof and to use thereof for the prophylaxis or treatment of diseases associated with blood coagulation factor XIII.
专利号:WO-9729091-A1 优先权日:1996-02-09 标题:Balanol analogues 发明人:NIELSEN JOHN; LYNGSOE LARS OLE 权利人:AUDA PHARMACEUTICALS APS; NIELSEN JOHN; LYNGSOE LARS OLE 摘要:The present invention relates to a solid phase methodology for the preparation of a combinatorial library of structural analogues of the natural product balanol (ophiocordin, azepinostatin), which is a protein kinase C (PKC) and protein kinase A (PKA) inhibitor. The method comprises solid-phase synthesis of the analog variants of balanol whereby a high molecular diversity is introduced. The synthetic scheme is based on a retrosynthetic analysis of the native structure which revealed three main building blocks suitable as templates for modification. The dicarboxy-functional moiety can be immobilised to the polymer support either as the monoallyl ester or as the internal anhydride. The libraries produced by the method are especially suited for high throughput screening of potential drug candidates for the treatment of mammals, especially humans.